<DOC>
	<DOCNO>NCT01138254</DOCNO>
	<brief_summary>Vascular access complication lead cause morbidity hemodialysis ( HD ) patient , responsible significant percentage hospitalization , annual cost approach one billion dollar United States . Thrombosis common cause vascular access failure , usually develop stenotic lesion venous outflow tract . It report far infrared ( FIR ) therapy improve access flow unassisted patency AV fistula , however , effect FIR cardiac function unknown . The aim study evaluate ( 1 ) change access flow AV fistula effect AV fistula echocardiographic parameter ( 2 ) effect FIR access flow AVF echocardiographic parameter serum level endothelial marker patient end stage renal disease ( ESRD ) first 6 month creation AV fistula .</brief_summary>
	<brief_title>Far Infrared Therapy AV Fistula Flow , Endothelial Function Echocardiography ESRD Patients</brief_title>
	<detailed_description>For patient end stage renal disease receive hemodialysis ( HD ) treatment , well-functioning vascular access necessary achieve adequate dialysis improve quality life . Among several type vascular access , long-term technical survival best native arteriovenous fistula ( AVF ) , account 80 % vascular access HD patient Taiwan . Vascular access complication account 20 % HD patient hospitalization United States cost $ 1 billion annually ( 1 ) . Malfunction vascular access usually present inadequate blood flow stenosis thrombosis venous outflow tract ( 2 ) . About 80 85 % AV access failure arise AV access thromboses , 80 % result AVF stenoses ( 3 ) . An access flow ( Qa ) less 500 ml/min associate increase risk access failure predictive poorer unassisted patency native AVF ( 4 ) . The pathological feature stenosis vascular access compose intimal hyperplasia ; proliferation smooth muscle cell medium subsequent migration intima , excessive accumulation extracellular matrix ( 5 ) . In spite finding , little information available effectively prevent stenosis vascular access HD patient . Infrared radiation invisible electromagnetic wave longer wavelength visible light . According difference wavelength , infrared radiation divide three category : near-infrared radiation ( 0.8-1.5μm ) , middle-infrared radiation ( 1.5-5.6μm ) far-infrared ( FIR ) radiation ( 5.6-1000μm ) ( 6 ) . Infrared radiation transfer energy perceive heat thermo- receptor surround skin ( 7 ) . The application FIR radiation include food preservation ( 8 ) health promotion ( 9-10 ) . Animal study also demonstrate FIR improves skin blood flow ( 11-12 ) , lead use FIR treatment ischemic lesion necrosis skin tissue due trauma , diabetes mellitus peripheral arterial occlusive disease . In addition , study indicate FIR therapy may improve endothelial function reduce frequency cardiovascular disease ( 13-15 ) . The thermal effect FIR result vasodilatation may increase access flow AV fistula . According report Vaupel et al. , temperature increase 4°C 10 mm depth tissue ( 16 ) . In addition , infrared therapy may allow multiple energy transfer deep 2-3 cm subcutaneous tissue without irritate overheat skin like unfiltered heat radiation ( 17 ) . The skin temperature steadily increase plateau around 38~39 °C treatment FIR 30 60 minute long distance ceramic plate skin 20 cm ( 11 ) . Therefore , infrared therapy free disadvantage side effect ( burn injury , infection , risk access failure prolong bleed previous venopuncture site ) traditional method thermal therapy . In addition thermal effect , three possible non-thermal effect infrared therapy report literature , include ( 1 ) improve endothelial function , ( 2 ) inhibit intimal hyperplasia , ( 3 ) decrease oxidative stress . FIR may improve endothelial function observe animal study ( 11,12,14 ) also one clinical study ( 13 ) . Yu et al . suggest beneficial effect FIR therapy skin blood flow may relate L-arginine/NO pathway ( 11 ) . In respect , Akasaki et al . find repeat FIR therapy could up-regulate eNOS expression augment angiogenesis apolipoprotein E-deficient mouse model unilateral hind limb ischemia ( 12 ) . Moreover , Ikeda et al . report 4 week sauna therapy significantly increase serum nitrate concentration well expression mRNA protein eNOS aorta TO-2 hamster ( 14 ) . In addition , Imamura et al . show two week repeat sauna therapy significantly improve vascular endothelial function , result increase flow-mediated endothelium-dependent dilatation brachial artery 4 % 5.8 % patient coronary risk factor ( 13 ) . In addition enhance eNOS expression , Kipshidze et al . find nonablative infrared laser ( NIL ) therapy inhibit neointimal hyperplasia PTCA cholesterol-fed rabbit 60 day ( 18 ) . According report , nonablative dos NIL decrease growth vascular smooth muscle cell ( VSMC ) , decrease growth rate endothelial cell . As proliferation VSMCs medium important pathological finding vascular wall HD patient vascular access stenosis ( 5 ) , slow growth VSMCs may reduce frequency access stenosis . According report Masuda et al . ( 19 ) , systolic blood pressure increase urinary 8-epi-prostaglandin F2α level significantly low patient receive FIR dry sauna 45 minute per day two week . F2-isoprostanes , namely 8-epi-prostaglandin F2α , chemically stable product lipid peroxidation level suggest reliable marker oxidative stress vivo ( 20 ) . These result suggest repeat sauna therapy may reduce oxidative stress , lead protection progression complication atherosclerosis . Since HD patient also expose heavy oxidative stress inward uremic status outward HD-related technology , application FIR therapy may consider alternative therapeutic modality decrease oxidative stress . Nakhoul et al . show high incidence unexplained pulmonary hypertension ( PHT ) end-stage renal disease ( ESRD ) patient chronic haemodialysis ( HD ) therapy via arterio-venous ( A-V ) access [ 21 ] . Pulmonary artery pressure ( PAP ) evaluate use Doppler echocardiography . Levels ET-1 NO metabolites plasma determine HD procedure compare subgroup patient without PHT . Out 42 HD patient study , 20 patient ( 48 % ) high PHT ( PAP = 46+/-2 mmHg ) rest normal PAP ( 29+/-1 mmHg ) ( P &lt; 0.0001 ) . In comparison HD patient without PHT , HD patient PHT high cardiac output ( 6.0+/-1.2 v 5.2+/-0.9 l/min , P &lt; 0.034 ) , similar plasma ET-1 level ( 1.6+/-0.7 vs. 2.4+/-0.8 fmol/ml ) , low basal plasma level NO2 + NO3 ( 14.3+/-2.3 μM vs. 24.2+/-5.2μM , P &lt; 0.05 ) , low HD-induced increase plasma NO metabolite ( 14.3+/-2.3 39.9+/-11.4 microM , P &lt; 0.007 vs. 24.2+/-5.2 77.1+/-9.6μM , P &lt; 0.0001 , respectively ) . Temporary closure A-V access sphygmomanometer eight patient PHT result transient decrease CO ( 6.4+/-0.6 5.3+/- 0.5 l/min , P = 0.18 ) systolic PAP ( 47.2+/-3.8 34.6+/-2.8 mmHg , P &lt; 0.028 ) . In summary , study demonstrate high prevalence PHT among patient ESRD chronic HD via surgical A-V fistula . In view vasodilatory antimitogenic property NO , possible attenuate basal HD-induced NO production patient PHT contributes increase pulmonary vascular tone . Furthermore , partial restoration normal PAP CO HD patient underwent either temporal A-V shunt closure successful transplantation indicate excessive pulmonary blood flow involve pathogenesis disease . Importance study : AV fistula may impose significant impact cardiac function echocardiographic parameter . FIR demonstrate increase access flow AV fistula prevalent HD patient . However , role newly-created AV fistula know . This study reveal effect FIR therapy echocardiographic parameter , access flow AVF endothelial function patient end stage renal disease . If FIR therapy associate beneficial hemodynamic effect ESRD patient , may consider therapeutic modality improve endothelial function cardiac performance ESRD patient .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Fistula</mesh_term>
	<criteria>( 1 ) age 18 80 , ( 2 ) chronic kidney disease ( CKD ) stage 5 clearance creatinine ( CCr ) less 15 ml/min , ( 3 ) receive dialysis renal transplantation , ( 4 ) go receive creation AV fistula standardize surgical procedure venous endtoarterial side anastomosis upper extremity . ( 1 ) creation AV graft Perm catheter type vascular access , ( 2 ) heart failure NYHA Fc III IV , ( 3 ) episode unstable angina , myocardial infarction , cerebrovascular event receive percutaneous coronary intervention therapy ( PCI ; include angioplasty placement stent ) within 3 month prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>flow , echocardiography , far infrared therapy , nitric oxide</keyword>
</DOC>